Arizona Tribune - Boulevard

NYSE - LSE

CMSC	-0.53%	21.93	$
CMSD	-0.73%	21.77	$
JRI	1.64%	12.79	$
NGG	-0.49%	83.01	$
BCE	-1.22%	22.92	$
BCC	1.56%	81.02	$
RIO	-1.46%	93.74	$
AZN	1.45%	188.41	$
GSK	1.16%	52.5	$
VOD	0.22%	13.89	$
RBGPF	5.69%	65	$
RYCEF	2.12%	18.39	$
RELX	1.34%	31.34	$
BTI	0.45%	62.76	$
BP	-1.59%	37.13	$

Featured

Venezuela quakes kill 1,400 as time running out to find survivors

Rescue crews raced Saturday to find survivors in the rubble of Venezuela's powerful earthquakes as the death toll reached 1,430 and hopes dwindled 72 hours after the earth roared and rumbled.

A painful wait by a pile of rubble in quake-hit Venezuela

Rescue crews working at one of the many buildings destroyed in Venezuela's killer earthquakes called for silence as they heard some kind of sound from a survivor buried in the rubble.

Last news

New to The Street Signs Medicus Pharma Ltd. (NASDAQ:MDCX) to Transformational 12-Part National Media Series Highlighting SkinJect(TM) and Teverelix(R) Platforms

NEW YORK CITY, NY / ACCESS Newswire / April 7, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX), a precision-guided biotech and life sciences company advancing innovative therapeutic platforms, has entered into a 12-part, one-year strategic media agreement with New to The Street to expand its national and international visibility across television, digital, and outdoor platforms.

Jaguar Health Reports 2025 Financials

Net revenue increase of 5% in Q4 2025 vs. Q3 2025Jaguar received an up-front payment of $16Mof non-dilutive capital in January 2026 upon entering U.S. license agreement with Future Pak for Mytesi® and Canalevia®-CA1 - Jaguar's commercialized crofelemer drugs - with an additional $2 million due upon completion of post-closing conditions; and has received $3.0 of up to $20 million in milestone payments and other future paymentsAgreement with Future Pak is fully aligned with Jaguar's strategy to concentrate crofelemer development efforts on human rare-disease intestinal failure indications moving forwardJaguar will appeal Nasdaq's March 5, 2026 noncompliance determination related to Nasdaq Listing Rule 5550(a)(2) at a hearing on April 7, 2026; delisting is stayed pending the panel's final decisionREMINDER: Friday, April 10, Jaguar to host investor webcast at 8:30 a.m. Eastern regarding Q4 2025 financials and company updates; Click here to register

Innovation Beverage Group and BlockFuel Energy Provide Operational Update on Well Reactivation, Initial Production and Development Progress

SYDNEY, AU / ACCESS Newswire / April 7, 2026 / Innovation Beverage Group Ltd ("IBG" or the "Company") (Nasdaq:IBG), an innovative developer, manufacturer, and marketer of a growing beverage portfolio of 60 formulations across 13 alcoholic and non-alcoholic brands, along with its proposed merger partner BlockFuel Energy ("BFE"), a Texas-based energy corporation, today provided an operational update on its ongoing well reactivation program, initial production performance, and development planning activities across its Central Oklahoma asset base.

Medical Care Technologies Builds on Strong Annual Results as Snapshot Recipes iHeart Podcast Campaign Goes Live Today

MESA, AZ / ACCESS Newswire / April 7, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) ("the Company") today provided an update as its previously announced podcast marketing campaign for Snapshot Recipes officially goes live today, marking a continued step forward following the Company's recently reported strong annual results.

Ensysce Biosciences Secures Second Financing From 2025 Agreement to Advance Breakthrough Pain Programs

~Continued funding underscores investor confidence and supports advancement of abuse- and overdose-resistant analgesics~

InterContinental Hotels Group PLC Announces Transaction in Own Shares - April 07

LONDON, UK / ACCESS Newswire / April 7, 2026 / The Company announces that on 02 April 2026 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 17 February 2026, as announced on 17 February 2026.

BioNxt Secures Unitary European Patent for Sublingual Cladribine ODF Platform Across 18 Countries

VANCOUVER, BC / ACCESS Newswire / April 7, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce the official registration of unitary effect for European Patent No. 4539857 covering the Company's proprietary sublingual cladribine oral thin film (ODF) platform.

Trump says Iran ceasefire proposal 'not good enough'

US President Donald Trump said Monday that a proposed 45-day ceasefire with Iran was a "very significant step" but "not good enough" for him to sign, as Iranian officials vowed to keep fighting.

In El Salvador's mass trials, 'the innocent pay for the guilty'

Wearing white uniforms, their heads shaved, rows of bewildered-looking men are beamed by video link from prisons across El Salvador into a courtroom conducting a mass trial of alleged gang members.

Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026

CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present late-breaking oral presentations on revaccination data for both mRNA-1010, its investigational seasonal influenza vaccine, and for mRESVIA® (mRNA-1345), its mRNA respiratory syncytial virus (RSV) vaccine, at the 2026 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress in Munich, Germany, on April 17-21, 2026.

NX Development Corp Submits Supplemental New Drug Application to FDA for MEN-301 Study

LEXINGTON, KY / ACCESS Newswire / April 6, 2026 / NX Development Corp (NXDC) is pleased to announce that after successfully completing the data analysis of our MEN-301 Study of the use of Gleolan® (aminolevulinic acid HCl) to enhance visualization of newly diagnosed or recurrent meningioma, we have submitted these data to the FDA for review as part of an efficacy supplement to our Gleolan New Drug Application (NDA).

Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q4:25 Quarterly Update

NEW YORK CITY, NY / ACCESS Newswire / April 6, 2026 / Emerging Growth Research today announced the release of its Quarterly Update Report on SBC Medical Group Holdings, Inc. (Nasdaq:SBC), reiterating a Buy-Extended rating and maintaining its 12-month price target of $9.00, representing potential upside from the Company's closing price of $4.47 on April 3, 2026.

Revolutionary Cancer Company Oncosure Testing Announces New Non-Executive Advisory Board

HHS AND CMS HEALTHCARE ADVISORY BOARD COMMITTEE MEMBER ELIZABETH FAGO APPOINTED TO CHAIR ONCOSURE NON-EXECUTIVE ADVISORY BOARD

MyPlanAdvocate Rebrands as MPA and Integrates HealthyLabs, Bringing AI-Powered Performance Marketing In-House

New identity reflects the company's evolution into a platform for licensed professionals; HealthyLabs acquisition adds AI-driven lead generation, multi-channel campaign management, and real-time routing to MPA's capabilities

TrustNFT Releases White Paper on Corporate Costs of Email Impersonation, Documenting $2.9 Billion in Annual Losses and Growing Brand Liability Risk

New research details financial, reputational, and regulatory damage facing utilities, banks, and insurers whose brands are weaponized by criminal phishing operations

Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board

SAN DIEGO, CA / ACCESS Newswire / April 6, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat acute and chronic disease, today announced formation of an Acute Kidney Injury (AKI) Advisory Board for the upcoming Phase 2/3 AKI clinical trial. This distinguished panel brings together internationally recognized Nephrologists and Critical Care Physicians who will guide the company's clinical strategy, monitor progress, and ensure the initiative achieves the goal of improving patient care by advancing Gemini for the treatment of AKI. Their collective insight will help inform the most pertinent study design to best address the significant unmet medical need in AKI.

Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year

FORT LAUDERDALE, FL / ACCESS Newswire / April 6, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) ("Sunshine Biopharma" or the "Company"), a pharmaceutical company offering and developing life‑saving medicines across oncology, antivirals, and other key therapeutic areas, today announced the filing of its Annual Report on Form 10‑K for the fiscal year ended December 31, 2025.

MDCE's Snapshot Recipes App Scales Marketing Strategy Beyond Initial Podcast Deals with Expanded iHeart Campaign

New iHeart podcast campaign builds on previously announced shows, targeting over 1 million additional impressions across dozens of top-tier podcast programs.

Trumps FDA CBD Enforcement Shift Signals a Turning Point - Why MMJ International Holdings is the Sector's Opportunity

Duane Boise CEO stated, "As cannabinoid policy shifts from retail access toward physician directed treatment and insurance participation, companies with IND programs, orphan-drug positioning, and botanical drug pipelines-like MMJ International Holdings-are emerging as the sector's most strategically aligned opportunities".

Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference

RANCHO CUCAMONGA, CA / ACCESS Newswire / April 6, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") announced today that Bill Peters, CFO, Tony Marrs, EVP of Regulatory Affairs and Clinical Operations, and Dan Dischner, SVP of Corp. Communication, will be presenting at the 25th Annual Needham Healthcare Conference on Tuesday, April 14, 2026, at 11:45 am ET. For access to the webcast, visit Amphastar Pharmaceuticals' website at http://ir.amphastar.com. This webcast will be available for 30 days following the presentation.

Bioz and Vilber Advance Evidence-Driven Scientific Marketing with Custom Publication Integration

PALO ALTO, CA / ACCESS Newswire / April 6, 2026 / Bioz, Inc., the AI-powered citation management platform for research, announced its collaboration with Vilber, a leading manufacturer of imaging and analysis systems for molecular biology and life science laboratories. Through a highly customized Bioz Badges implementation, Vilber is enhancing scientific transparency across its digital portfolio while delivering added value to both direct customers and global distributors.

'Choose peace': Pope marks first Easter under cloud of Mideast war

Pope Leo XIV on Sunday urged "those who have the power to unleash wars" to "choose peace" in in his first Easter blessing as pontiff with the Middle East conflict raging.

Afghan mother seeks justice after Pakistani bombing kills hundreds

Samira Muhammadi hopes an international investigation can "extinguish" her pain after a Pakistani bombing killed her son and hundreds of other Afghans in the capital Kabul last month.

UK royal family's dilemma over Andrew's daughters

The downfall of the former prince Andrew has left the British monarchy with a right royal headache -- how to handle his daughters caught up in the scandal of US sex offender Jeffrey Epstein.

Pope marks first Easter under cloud of Mideast war

Pope Leo XIV is set to mark Easter Sunday for the first time as pontiff, with the Middle East war casting a pall over the most important date in the Christian calendar.

Police arrest suspect in Jewish ambulance arson case in court

London police announced Saturday they had arrested another man over an arson attack on ambulances run by a Jewish charity in London -- after officers recognised him at a court hearing over the incident.

Rain, storms kill 121 in Afghanistan and Pakistan in two weeks

Heavy rain and storms have killed at least 121 people over two weeks across Afghanistan and Pakistan, disaster officials in both countries said Saturday.

Belgian prison tour lays bare grim reality of life behind bars

As Belgium grapples with chronic prison overcrowding, a local charity in Brussels has found an immersive way to highlight the problem -- giving educational tours of a recently abandoned jail.

58 tortillas, five hot sauces and one toilet: life aboard spacecraft Orion

They're sipping smoothies, snapping phone pics, dealing with crashed email and fixing broken toilets: astronauts, they're just like us.

New to The Street Announces Episode 741 Airing Tonight on Bloomberg Television at 6:30 PM EST Featuring Canton Networks, Acme Markets, Virtuix Holdings (VTIX), HPB, Jonas & Redman, Acurx Pharmaceuticals (ACXP), and FreeCast (CAST)

NEW YORK CITY, NY / ACCESS Newswire / April 4, 2026 / New to The Street, one of the longest-running U.S. and international business television brands, today announced the broadcast of Episode 741, airing tonight as sponsored programming on Bloomberg Television at 6:30 PM EST across the United States, with additional distribution across international markets.

Pope leads torch-lit Colosseum procession before Easter

Pope Leo XIV led a torch-lit procession at the Colosseum in Rome on Friday as he prepares for his first Easter as pontiff in the shadow of war in the Middle East.

French court rules to extradite Russian who owned Portsmouth football club

A French court has ruled to extradite Russian banker Vladimir Antonov, a former owner of English football club Portsmouth, to Lithuania, his lawyer said on Friday.

Arizona Tribune - Boulevard (English)